Axsome Therapeutics has an exciting late-stage pipeline. Madrigal Pharmaceuticals is looking to dominate a large market with significant unmet needs.
Source: https://www.fool.com/investing/2026/03/10/2-under-the-radar-…
Axsome Therapeutics has an exciting late-stage pipeline. Madrigal Pharmaceuticals is looking to dominate a large market with significant unmet needs.
Source: https://www.fool.com/investing/2026/03/10/2-under-the-radar-…